Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Reckitt ( (GB:RKT) ) has issued an update.
Reckitt Benckiser Group plc has launched the third tranche of its previously announced £1 billion share buyback programme, committing up to a further £540 million to be returned to shareholders by no later than 27 July 2026. The repurchased ordinary shares, which will be executed on the London Stock Exchange and related venues under an agreement with Deutsche Bank, will be held in treasury, underscoring Reckitt’s ongoing focus on capital returns and balance-sheet efficiency for investors.
This latest tranche follows two earlier phases that together have already returned hundreds of millions of pounds to shareholders, including £206 million completed under the second tranche in January 2026. By continuing to shrink its share capital rather than repurchasing American Depository Receipts, Reckitt is reinforcing its commitment to shareholder value and signalling confidence in its financial position within the competitive consumer health and hygiene sector.
The most recent analyst rating on (GB:RKT) stock is a Buy with a £6501.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.
Spark’s Take on GB:RKT Stock
According to Spark, TipRanks’ AI Analyst, GB:RKT is a Neutral.
The score is driven primarily by improved financial performance (notably profitability and lower leverage) and supportive valuation (moderate P/E and solid yield). These are tempered by weak technicals (below key moving averages with negative momentum) and earnings-call-flagged near-term pressures on cash flow, leverage, and 2026 margin/EPS visibility.
To see Spark’s full report on GB:RKT stock, click here.
More about Reckitt
Reckitt Benckiser Group plc is a global consumer goods company focused on health, hygiene and home products, with a portfolio that includes brands such as Dettol, Durex, Finish, Gaviscon, Lysol, Nurofen and Vanish. The group targets everyday consumer health and hygiene needs with science-backed solutions, while pursuing sustainability initiatives that expand access to healthcare, education and economic opportunities.
Average Trading Volume: 2,047,005
Technical Sentiment Signal: Buy
Current Market Cap: £35.99B
Find detailed analytics on RKT stock on TipRanks’ Stock Analysis page.